Amneal Pharmaceuticals
AMRX · Mid Cap · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$20.20−$0.30 (-1.46%)
Opens in 53:15Next open: 9:30 AM ETFree AI brief
Get the full brief on AMRX
Free to track. No card required. Usually ready in 10-15 minutes.
Where AMRX sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$7.67
High$19.26
Today $20.20
RSI (14)
70.4Overbought
03070100
Stocksbrew score
67/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$20
Current price
$20.2
Median target
$22
Highest
$27
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 17% below avg
19.68x
Price / sales
Strong · Low price-to-sales
2.21x
ROIC
Strong · Excellent capital returns
18.6%
ROE
Favorable · 613.0% - strong capital efficiency
613.0%
Current ratio
Strong · Good liquidity position
2.20x
⚠ Things to watch
Price / FCF
Rich · Expensive vs. cash flow
82.85x
Debt / equity
Needs attention · Unfavorable
23.87x
How it stacks up against its peers
AMRX against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $6.31B | 41.3 | +9.3% | 67 |
 | $10.01B | 19.1 | +19.7% | 78 |
 | $32.69B | 34.2 | +15.5% | 78 |
 | $4.23B | 12.7 | +13.5% | 78 |
 | $1.11T | 40.2 | +49.6% | 77 |